Previous 10 | Next 10 |
FREMONT, CA - ( NewMediaWire ) - February 15, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a definitive agree...
FREMONT, CA , Feb. 12, 2024 (GLOBE NEWSWIRE) -- The Company holds a U.S. patent for the same treatment via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurolo...
FREMONT, CA, Feb. 08, 2024 (GLOBE NEWSWIRE) -- via NewMediaWire – ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in Oncology/Hematology, Neurology, and Ophthalmology, announced today that it signed a defi...
2024-01-12 17:08:09 ET More on ABVC BioPharma ABVC Biopharma and unit receive $460M as first milestone payment; shares jump For further details see: ABVC BioPharma files to sell 10.4M shares for holders
2024-01-04 12:34:16 ET More on Mid-day movers & Stocks. Relmada Therapeutics, Inc. (RLMD) Q3 2023 Earnings Call Transcript Relmada And REL-1017: Intriguing Underlying Efficacy In MDD Ahead Of Eventful 2024 Avenue Therapeutics GAAP EPS of $0.06 beats by $0.32 ...
2024-01-04 10:00:14 ET More on Health Care Select Sector SPDR XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Covid-vaccine makers top laggard list, LLY and WST top gainers list Healthcare and uti...
2024-01-04 08:31:40 ET Losers: Mobileye Global ( MBLY ) -27% releases preliminary FY2023 financial results and initial 2024 outlook . Opko Health OPK -16% commences private offering of convertible senior notes . Neximmune ( NEXI ) -16% . Mmtec (...
2024-01-03 19:51:02 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- 24/7 Market News covered the following companies today; ABVC BioPharma, Inc. (NASDAQ: ABVC), Neximmune Inc (NASDAQ: NEXI), Sidus Space Inc (NASDAQ: SIDU), Voyager Therapeutics Inc (NASDAQ: VYGR), and Cingulate...
2024-01-03 12:43:51 ET More on Mid-day movers & stocks. Tenax falls as rally driven by IND clearance cools Tenax stock jumps after FDA greenlights studies for hypertension candidate Financial information for Airship AI Holdings, Inc. Financial information...
2024-01-03 12:20:37 ET DENVER, Colo., Jan. 3, 2024 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Sidus Space Inc (NASDAQ: SIDU), ABVC Biopharma Inc (NASDAQ: ABVC), Dyne Therapeutics Inc (NASDAQ: DYN),...
News, Short Squeeze, Breakout and More Instantly...
FREMONT, CA - ( NewMediaWire ) - July 02, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company and it...
The Company holds a U.S. patent for the same treatment FREMONT, CA - ( NewMediaWire ) - June 25, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, neurology, a...
FREMONT, CA - ( NewMediaWire ) - June 12, 2024 - ABVC BioPharma, Inc. (NASDAQ: ABVC) ("Company"), a clinical-stage biopharmaceutical company developing therapeutic solutions in ophthalmology, CNS (central nervous systems), and oncology/hematology, announced today that the Company receive...